(0.21%) 5 142.25 points
(0.20%) 38 517 points
(0.28%) 17 897 points
(-0.98%) $83.03
(1.61%) $1.954
(-0.12%) $2 344.30
(-0.07%) $27.52
(0.30%) $924.90
(-0.20%) $0.933
(-0.22%) $11.00
(-0.28%) $0.798
(1.10%) $92.89
Live Chart Being Loaded With Signals
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States...
Stats | |
---|---|
今日成交量 | 571 313 |
平均成交量 | 48 417.00 |
市值 | 1.73M |
EPS | $0 ( 2024-03-25 ) |
下一个收益日期 | ( $-0.720 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0700 |
ATR14 | $0.0150 (2.34%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-13 | Dey Svetlana | Buy | 500 | Common Stock |
2023-12-13 | Dey Indranil | Buy | 500 | Common Stock |
2023-09-26 | Scally Frances P | Buy | 0 | |
2023-03-24 | Dey Svetlana | Buy | 10 000 | Common Stock |
2023-03-28 | Dey Indranil | Buy | 2 000 | Common Stock |
INSIDER POWER |
---|
43.51 |
Last 55 transactions |
Buy: 889 772 | Sell: 456 992 |
Bluejay Diagnostics, Inc. 财务报表
Annual | 2023 |
营收: | $0 |
毛利润: | $-780 955 (0.00 %) |
EPS: | $-9.08 |
FY | 2023 |
营收: | $0 |
毛利润: | $-780 955 (0.00 %) |
EPS: | $-9.08 |
FY | 2022 |
营收: | $249 040 |
毛利润: | $48 911.00 (19.64 %) |
EPS: | $-9.15 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-0.275 |
Financial Reports:
No articles found.
Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。